Decoy Therapeutics Inc.
DCOY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001615219
No open-market purchases or sales by Decoy Therapeutics Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $31.0K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Decoy Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −7 vs. Q2 2021
- Shares held
- 6.71M
- −3.41M (−33.7%) vs. Q2 2021
- Total value
- $6.84M
- −$3.85M (−36.0%) vs. Q2 2021
- New holders
- 6
- 10 more added
- Sold out
- 13
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DCOY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $31.0K |
| Q1 2026 | 4 | $10.5K |
| Q4 2025 | 9 | $51.4K |
| Q3 2025 | 5 | $1.98K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 13 | $101.9K |
| Q4 2023 | 16 | $169.8K |
| Q3 2023 | 14 | $226.8K |
| Q2 2023 | 14 | $321.5K |
| Q1 2023 | 11 | $186.0K |
| Q4 2022 | 9 | $110.9K |
| Q3 2022 | 22 | $671.0K |
| Q2 2022 | 27 | $859.0K |
| Q1 2022 | 28 | $1.45M |
| Q4 2021 | 28 | $2.63M |
| Q3 2021 | 27 | $6.84M |
| Q2 2021 | 34 | $10.7M |
| Q1 2021 | 34 | $22.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Decoy Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 274 | $0 | 0.00% | +12+4.6% | Added |
| Investors Research Corp | 25 | $0 | 0.00% | +14+127.3% | Added |
| Koshinski Asset Management, Inc. | 645 | $658 | 0.00% | +645 | New |
| Tower Research Capital LLC (TRC) | 803 | $1.00K | 0.00% | +668+494.8% | Added |
| UBS Group AG | 6,400 | $7.00K | 0.00% | −100−1.5% | Reduced |
| Financial Advocates Investment Management | 11,472 | $12.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 12,023 | $12.0K | 0.00% | +12,023 | New |
| Two Sigma Investments, LP | 19,321 | $20.0K | 0.00% | +19,321 | New |
| Advisor Group Holdings, Inc. | 22,834 | $23.0K | 0.00% | +130+0.6% | Added |
| HighTower Advisors, LLC | 26,000 | $26.0K | 0.00% | +26,000 | New |
| Virtu Financial LLC | 29,708 | $30.0K | 0.00% | +29,708 | New |
| Bank of New York Mellon Corp | 35,506 | $36.0K | 0.00% | 00.0% | Unchanged |
| Wetherby Asset Management Inc | 39,746 | $41.0K | 0.00% | 00.0% | Unchanged |
| Monticello Wealth Management, LLC | 40,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Meitav Dash Investments Ltd | 52,000 | $53.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 59,480 | $61.0K | 0.00% | +25,992+77.6% | Added |
| Northern Trust Corp | 67,227 | $68.0K | 0.00% | +2,205+3.4% | Added |
| X-Square Capital, LLC | 100,658 | $103.0K | 0.05% | +200+0.2% | Added |
| Two Sigma Advisers, LP | 111,300 | $114.0K | 0.00% | +111,300 | New |
| BlackRock Inc. | 116,309 | $119.0K | 0.00% | −18,444−13.7% | Reduced |
| State Street Corp | 142,552 | $145.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 356,114 | $363.0K | 0.00% | +79,079+28.5% | Added |
| Kepos Capital LP | 548,054 | $559.0K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 759,772 | $775.0K | 0.00% | +268,970+54.8% | Added |
| Maven Securities LTD | 1,212,575 | $1.24M | 0.14% | −103,630−7.9% | Reduced |
| Sio Capital Management, LLC | 1,354,291 | $1.38M | 0.45% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,585,020 | $1.62M | 0.00% | +40,296+2.6% | Added |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −1,800,000−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −585,409−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −471,885−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −424,800−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −249,033−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −174,474−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −85,436−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −36,634−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −29,683−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −21,741−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,412−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |